LexaGene: LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

(marketscreener.com) BEVERLY, Mass., Jan. 18, 2023 -- LexaGene Holdings, Inc., , an innovative, molecular diagnostics company that has commercialized the MiQLabTM System for automated, genetic testing, is pleased to announce exciting news regarding the ability of the MiQLab System to detect Mycoplasma at minute levels. Dr. Jack Regan, CEO and Founder of...https://www.marketscreener.com/quote/stock/LEXAGENE-HOLDINGS-INC-49479172/news/LexaGene-s-MiQLab-System-Detects-Mycoplasma-at-Minute-Levels-Rousing-Additional-Interest-from-BioPh-42758556/?utm_medium=RSS&utm_content=20230118